CLINICAL_TRIALS
trial_result
· 2011-06-27
Clinical Trial Update: Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122) [Phase 1]
Summary
Phase 1 bioequivalence study evaluating a sitagliptin/metformin combination tablet (MK0431A-122) in adults with Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2011-06-27